Medical Advisors


Chi Van Dang, M.D., Ph.D.

Chairman of the Medical Advisory Board

Director of the Abramson Cancer Center of the University of Pennsylvania. Dr. Dang is considered by many to be the world’s leading authority on cancer metabolism and serves as Rafael’s Chairman of the Scientific and Medical Advisory Boards. Dr. Dang is also serving on Rafael’s Board of Directors.


Pancreatic Cancer Advisors:

Philip A. Philip, M.D., Ph.D., FRCP

Professor of Oncology and Pharmacology, Leader, GI and Neuroendocrine Oncology, Vice President of Medical Affairs, Karmanos Cancer Center, Wayne State University, Detroit, MI

Jordan D. Berlin, M.D.

Co-Leader, Gastrointestinal Cancer Research Program, Professor of Medicine (Hematology/Oncology), Director, Phase I Program, Medical Oncologist, Vanderbilt-Ingram Cancer Center

J. Randolph Hecht, M.D.

Director, Gastrointestinal Cancer Program, Professor of Clinical Medicine, David Geffen School of Medicine at UCLA

Heloisa P. Soares, M.D., Ph.D.

Medical Oncologist, Department of Gastrointestinal Oncology, Moffitt Cancer Center


Acute Myeloid Leukemia Advisors:

Jorge Cortes, M.D.

Deputy Chair and Professor of Medicine in the Department of Leukemia at The University of Texas MD Anderson Cancer Center

Bayard L. Powell, M.D.

Section Chief, Hematology & Oncology, Associate Director for Clinical Research, Comprehensive Cancer Center, Professor, Hematology & Oncology, Wake Forest Baptist Medical Center

Mikkael Sekeres, M.D.

Director, Leukemia Program, Vice-chair for Clinical Research, Cleveland Clinic’s Taussig Cancer Institute

Richard M. Stone, M.D.

Professor of Medicine, Harvard Medical School; Associate Physician, Medicine, Brigham And Women’s Hospital; Director, Adult Leukemia Program, Dana-Farber Cancer Institute


Lymphoma Advisors:

Craig H. Moskowitz, M.D.

Hematologist, Clinical Director of the Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center

Ariela Noy, M.D.

Hematologic oncologist for Lymphoma and AIDS-associated cancers, Memorial Sloan-Kettering Cancer Center; Chair of the Lymphoma Working Group for the AIDS Malignancy Consortium

Steven I. Park, M.D.

Division Chief, Hematology and Oncology, Levine Cancer Institute, CHS-Northeast; Director of Investigational Therapeutics in Hematologic Malignancies, Levine Cancer Institute/Carolinas HealthCare System; Associate Professor of Medicine, University of North Carolina, Chapel Hill

Medical Advisors


Chi Van Dang, M.D., Ph.D.

Chairman of the Medical Advisory Board

Director of the Abramson Cancer Center of the University of Pennsylvania. Dr. Dang is considered by many to be the world’s leading authority on cancer metabolism and serves as Rafael’s Chairman of the Scientific and Medical Advisory Boards. Dr. Dang is also serving on Rafael’s Board of Directors.


Pancreatic Cancer Advisors:

Philip A. Philip, M.D., Ph.D., FRCP

Professor of Oncology and Pharmacology, Leader, GI and Neuroendocrine Oncology, Vice President of Medical Affairs, Karmanos Cancer Center, Wayne State University, Detroit, MI

Jordan D. Berlin, M.D.

Co-Leader, Gastrointestinal Cancer Research Program, Professor of Medicine (Hematology/Oncology), Director, Phase I Program, Medical Oncologist, Vanderbilt-Ingram Cancer Center

J. Randolph Hecht, M.D.

Director, Gastrointestinal Cancer Program, Professor of Clinical Medicine, David Geffen School of Medicine at UCLA

Heloisa P. Soares, M.D., Ph.D.

Medical Oncologist, Department of Gastrointestinal Oncology, Moffitt Cancer Center


Acute Myeloid Leukemia Advisors:

Jorge Cortes, M.D.

Deputy Chair and Professor of Medicine in the Department of Leukemia at The University of Texas MD Anderson Cancer Center

Bayard L. Powell, M.D.

Section Chief, Hematology & Oncology, Associate Director for Clinical Research, Comprehensive Cancer Center, Professor, Hematology & Oncology, Wake Forest Baptist Medical Center

Mikkael Sekeres, M.D.

Director, Leukemia Program, Vice-chair for Clinical Research, Cleveland Clinic’s Taussig Cancer Institute

Richard M. Stone, M.D.

Professor of Medicine, Harvard Medical School; Associate Physician, Medicine, Brigham And Women’s Hospital; Director, Adult Leukemia Program, Dana-Farber Cancer Institute


Lymphoma Advisors:

Craig H. Moskowitz, M.D.

Hematologist, Clinical Director of the Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center

Ariela Noy, M.D.

Hematologic oncologist for Lymphoma and AIDS-associated cancers, Memorial Sloan-Kettering Cancer Center; Chair of the Lymphoma Working Group for the AIDS Malignancy Consortium

Steven I. Park, M.D.

Division Chief, Hematology and Oncology, Levine Cancer Institute, CHS-Northeast; Director of Investigational Therapeutics in Hematologic Malignancies, Levine Cancer Institute/Carolinas HealthCare System; Associate Professor of Medicine, University of North Carolina, Chapel Hill